Trial Profile

A Phase 3, Randomized, Modified Double-blind, Active-controlled, Parallel-group, 4-arm Study to Investigate the Mixed Vaccination Schedules of a 21-valent Pneumococcal Conjugate Vaccine and a 20-valent Pneumococcal Conjugate Vaccine in Healthy Infants and Toddlers

Status: Recruiting

Phase of Trial: Phase III

Latest Information Update: 11 May 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs SP-0202 (Primary) ; Hepatitis A vaccine inactivated; Hib-DTaP-hepatitis B-poliovirus vaccine; Measles mumps and rubella virus vaccine; Measles mumps and rubella virus vaccine; Measles mumps and rubella virus vaccine-(Priorix); Pneumococcal 20-valent conjugate vaccine; RIX 4414; Rotavirus W179-9 vaccine; Varicella zoster virus vaccine live; Varicella zoster virus vaccine live
Indications Pneumococcal infections
Focus Adverse reactions; Pharmacodynamics; Registrational
Sponsors Sanofi

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com